2013
DOI: 10.1158/1078-0432.ccr-12-2539
|View full text |Cite
|
Sign up to set email alerts
|

Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer

Abstract: Purpose: Despite continuous improvement of treatment regimes, the mortality rates for non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) remain disappointingly high and novel anticancer agents are urgently awaited.Experimental Design: We combined the data from genome-wide siRNA screens on tumor cell lethality in a lung and a head and neck cancer cell line.Results: We identified 71 target genes that seem essential for the survival of both cancer types. We identified a cluster o… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
59
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 70 publications
(62 citation statements)
references
References 38 publications
(44 reference statements)
3
59
0
Order By: Relevance
“…The SW1573 NSCLC cell line was subjected to a high-throughput forward transfection in 96-well plates as described before (9). Cells were seeded at a density of 200 cells per 96-well and were transfected 24 hours later.…”
Section: Sirna Screensmentioning
confidence: 99%
“…The SW1573 NSCLC cell line was subjected to a high-throughput forward transfection in 96-well plates as described before (9). Cells were seeded at a density of 200 cells per 96-well and were transfected 24 hours later.…”
Section: Sirna Screensmentioning
confidence: 99%
“…Two RNAi-based screenings identified TPX2 among essential genes for tumor survival and hence the most promising target candidates for anti-cancer strategies (Morgan-Lappe et al, 2007;Martens-de Kemp et al, 2013). Several studies provide direct demonstration of the antiproliferative effects of TPX2 inactivation in cancer cells of different tumor types (Morgan-Lappe et al, 2007;Zhang et al, 2008;Warner et al, 2009;Li et al, 2010;Satow et al, 2010;Chang et al, 2012;Vainio et TPX2 (TPX2, microtubule-associated, homolog (Xenopus laevis)) Asteriti IA, Guarguaglini G Atlas Genet Cytogenet Oncol Haematol.…”
Section: Notementioning
confidence: 99%
“…Several studies provide direct demonstration of the antiproliferative effects of TPX2 inactivation in cancer cells of different tumor types (Morgan-Lappe et al, 2007;Zhang et al, 2008;Warner et al, 2009;Li et al, 2010;Satow et al, 2010;Chang et al, 2012;Vainio et TPX2 (TPX2, microtubule-associated, homolog (Xenopus laevis)) Asteriti IA, Guarguaglini G Atlas Genet Cytogenet Oncol Haematol. 2013;17(9) al., 2012; Martens-de Kemp et al, 2013). In addition, TPX2 inactivation significantly reduced tumor growth in xenografts models based on inoculation in nude mice of pancreatic or hepatocellular carcinoma cells (Warner et al, 2009;Satow et al, 2010).…”
Section: Notementioning
confidence: 99%
“…A number of mitotic spindle-associated proteins have been implicated in multiple malignancies, including lung cancer (5,6). Overexpression and gene amplification have been reported to contribute to the development and progression of malignant tumours for a number of mitotic spindle genes, including those involved in centrosome maturation [e.g., Aurora kinase (AURK)A, microtubule nucleation factor TPX2 (TPX2) and kinesin-like protein 11 (KIF11)] (7,8), microtubule formation [e.g., AURKA, cytoskeleton-associated protein 5 (CKAP5), tubulin β (TUBB) and TUBB3] (9-11), and chromosomal alignment and segregation [e.g., AURKA, AURKB, AURKC, discs large-associated protein 5 (DLGAP5) and TTK protein kinase (TTK)] (12)(13)(14).…”
Section: Introductionmentioning
confidence: 99%